ATLANTA, GA – – (Newsfile Corp. – September 25, 2020) – – Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Odonate Therapeutics, Inc.  (“Odonate” or the “Company”) (NASDAQ: ODT) securities between December 7, 2017 and August 21, 2020 (the “Class Period”). Investors who purchased the Company’s securities during the Class Period and are interested in serving as lead plaintiff are encouraged to contact the firm before the November 16, 2020 deadline. The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) tesetaxel was not as safe or well-tolerated as the Company had led investors to believe; (ii) consequently, tesetaxel’s commercial viability as a cancer treatment was overstated; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times. If you purchased shares of Odonate securities between December 7, 2017 and August 21, 2020 and suffered significant losses on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com, or through www.holzerlaw.com to discuss your legal rights.

Provide Your Information To Take Action

  • Plaintiff Certifies That:
    1. Plaintiff has reviewed the complaint and authorized its filing.
    2. Plaintiff did not acquire the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this private action or any other litigation under the federal securities laws.
    3. Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.
    4. Plaintiff represents and warrants that he/she/it is fully authorized to enter into and execute this certification.
    5. Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond the Plaintiff's pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the class as ordered or approved by the court.
    6. Plaintiff has made no transaction(s) during the Class Period in the debt or equity securities that are the subject of this action except those set forth below:
  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
  • Date SoldNumber of Shares SoldSelling Price Per Share 
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt